MicuRx announced that its operating revenue in the first half of 2025 was 66.9698 million yuan, a year-on-year increase of 10.26%. The net loss attributable to shareholders of the listed company was 139 million yuan, compared to a net loss of 201 million yuan in the same period last year. The basic earnings per share were -0.21 yuan/share, compared to -0.31 yuan/share in the same period last year